secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALLURION TECHNOLOGIES, INC. (ALUR)
CIK:        0001964979
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002703
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allurion prelim 2023 rev $53-54M, cuts 30% staff, 2024 outlook $60-65M
----------------------------------------------------------------------

- Full-year 2023 revenue expected $53-54M; gross margin 77-78%; procedural volume up 30% YoY.
- Q4 2023 revenue expected $8.1-8.3M; European procedural volume grew 44% in Q4 vs prior year.
- Cash balance $38M as of Dec 31, 2023; Q4 cash burn $22M; term loan reduced by $20M to $40M.
- Reduced headcount ~30% since Dec 2023 to cut quarterly cash burn to $7-8M in 2024.
- 2024 outlook: revenue $60-65M, procedural volume growth ~20%, gross margins 77-79%; FDA pivotal trial readout (AUDACITY) expected by year-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964979/000095017024002703/0000950170-24-002703-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964979/000095017024002703/alur-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002703

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer